Rheumatoid Arthritis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: RA patient by whom the consent to this research was got while going to hospital regularly to this department (under visitors and hospitalization)
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of abnormalities of imaging at 52 week after introduction of anti-rheumatic drugs | — |
Secondary
| Measure | Time frame |
|---|---|
| Association of improvement of clinical indices, biomarkers and image findings. | — |
Countries
Japan
Contacts
Nagasaki University Hospital Department of Immunology and Rheumatology Nagasaki University Graduate School of Biomedical Sciences